Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

807
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
807
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

511
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
511

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Idiopathic scrotal calcinosis: report of three cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2026
Same author

[Characterization of liver macrophage subsets in different mouse models of metabolic associated steatohepatitis].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2026
Same author

[Analysis of the efficacy and safety of magaldrate granules quadruple therapy in the treatment of <i>Helicobacter pylori</i> infection].

Zhonghua yi xue za zhi·2026
Same author

[Clinical classification of pediatric non-alcoholic fatty liver disease based on pancreatic islet function].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2026
Same author

Novel and simple technique to prevent internal hernias after laparoscopic left-sided colorectal resection: alignment and fixation of the proximal jejunum.

Techniques in coloproctology·2025
Same author

Sacituzumab tirumotecan in participants with advanced or metastatic urothelial carcinoma and disease progression after chemotherapy and immune checkpoint inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Related Experiment Video

Updated: Mar 8, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

9.3K

[Cost-effectiveness analysis on colorectal cancer screening program].

Q C Huang1, D Ye1, X Y Jiang1

  • 1Department of Epidemiology, School of Public Health, Zhejiang University, Hangzhou 310058, China.

Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|January 20, 2017
PubMed
Summary
This summary is machine-generated.

Starting colorectal cancer screening at age 50 is more cost-effective. This approach improves the efficiency of screening programs by focusing on older individuals, yielding better health economic outcomes.

Keywords:
Colorectal cancerCost-effectivenessScreening

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

978
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.0K

Related Experiment Videos

Last Updated: Mar 8, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

9.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

978
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.0K

Area of Science:

  • Health Economics
  • Public Health
  • Gastroenterology

Background:

  • Colorectal cancer (CRC) screening is crucial for early detection and improved patient outcomes.
  • Determining the optimal age to initiate CRC screening is essential for maximizing program efficiency and resource allocation.

Purpose of the Study:

  • To assess the cost-effectiveness of CRC screening programs across different age demographics from a health economic standpoint.
  • To identify age-specific detection rates and cost-effectiveness ratios for CRC screening interventions.

Main Methods:

  • Utilized data from a CRC screening program in Jiashan county, Zhejiang province.
  • Calculated screening compliance and detection rates (iFOBT positivity, advanced adenoma, CRC, early-stage CRC) by age group.
  • Analyzed age-related differences using chi-squared tests and calculated cost-effectiveness ratios.

Main Results:

  • Detection rates for iFOBT positivity, advanced adenoma, CRC, and early-stage CRC increased with age.
  • Early diagnosis rates showed a negative association with age.
  • Excluding younger individuals, the cost-effectiveness of screening individuals aged over 50 improved by 15%-30%.

Conclusions:

  • Initiating CRC screening at age 50 is recommended from a health economic perspective.
  • Targeting screening at age 50 enhances the overall efficiency of CRC screening programs.